Recombinant CMV gB Vaccine in Postpartum Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00125502

Recruitment Status : Completed

First Posted : August 1, 2005

Last Update Posted : September 20, 2011

Sponsor:

Collaborators:

National Institute of Allergy and Infectious Diseases (NIAID)

MCM Vaccines B.V.

Information provided by (Responsible Party):

Robert Pass, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	June 2007
Actual Study Completion Date :	January 2010

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Pass RF, Zhang C, Evans A, Simpson T, Andrews W, Huang ML, Corey L, Hill J, Davis E, Flanigan C, Cloud G. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med. 2009 Mar 19;360(12):1191-9. doi: 10.1056/NEJMoa0804749.

To Top